Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1968 1
1975 1
1976 1
1977 3
1978 1
1979 1
1981 1
1982 1
1990 2
1991 2
1992 5
1993 5
1994 3
1995 3
1996 7
1997 4
1998 4
1999 9
2000 1
2001 5
2002 1
2003 3
2004 4
2005 10
2006 9
2007 8
2008 10
2009 11
2010 9
2011 15
2012 6
2013 9
2014 13
2015 12
2016 8
2017 9
2018 8
2019 10
2020 6
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Results by year
Filters applied: . Clear all
Page 1
Clinical relevance of colorectal cancer molecular subtypes.
Rodriguez-Salas N, Dominguez G, Barderas R, Mendiola M, García-Albéniz X, Maurel J, Batlle JF. Rodriguez-Salas N, et al. Among authors: maurel j. Crit Rev Oncol Hematol. 2017 Jan;109:9-19. doi: 10.1016/j.critrevonc.2016.11.007. Epub 2016 Nov 23. Crit Rev Oncol Hematol. 2017. PMID: 28010901 Review.
The Tumor Microenvironment in Colorectal Cancer Therapy.
Pedrosa L, Esposito F, Thomson TM, Maurel J. Pedrosa L, et al. Among authors: maurel j. Cancers (Basel). 2019 Aug 14;11(8):1172. doi: 10.3390/cancers11081172. Cancers (Basel). 2019. PMID: 31416205 Free PMC article. Review.
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types.
Paré L, Pascual T, Seguí E, Teixidó C, Gonzalez-Cao M, Galván P, Rodríguez A, González B, Cuatrecasas M, Pineda E, Torné A, Crespo G, Martin-Algarra S, Pérez-Ruiz E, Reig Ò, Viladot M, Font C, Adamo B, Vidal M, Gaba L, Muñoz M, Victoria I, Ruiz G, Viñolas N, Mellado B, Maurel J, Garcia-Corbacho J, Molina-Vila MÁ, Juan M, Llovet JM, Reguart N, Arance A, Prat A. Paré L, et al. Among authors: maurel j. Ann Oncol. 2018 Oct 1;29(10):2121-2128. doi: 10.1093/annonc/mdy335. Ann Oncol. 2018. PMID: 30165419 Free article.
ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells.
de Barrios O, Sanchez-Moral L, Cortés M, Ninfali C, Profitós-Pelejà N, Martínez-Campanario MC, Siles L, Del Campo R, Fernández-Aceñero MJ, Darling DS, Castells A, Maurel J, Salas A, Dean DC, Postigo A. de Barrios O, et al. Among authors: maurel j. Gut. 2019 Dec;68(12):2129-2141. doi: 10.1136/gutjnl-2018-317294. Epub 2019 Jul 31. Gut. 2019. PMID: 31366457
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.
Van Cutsem E, Köhne CH, Láng I, Folprecht G, Nowacki MP, Cascinu S, Shchepotin I, Maurel J, Cunningham D, Tejpar S, Schlichting M, Zubel A, Celik I, Rougier P, Ciardiello F. Van Cutsem E, et al. Among authors: maurel j. J Clin Oncol. 2011 May 20;29(15):2011-9. doi: 10.1200/JCO.2010.33.5091. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502544 Clinical Trial.
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Van Cutsem E, Peeters M, Siena S, Humblet Y, Hendlisz A, Neyns B, Canon JL, Van Laethem JL, Maurel J, Richardson G, Wolf M, Amado RG. Van Cutsem E, et al. Among authors: maurel j. J Clin Oncol. 2007 May 1;25(13):1658-64. doi: 10.1200/JCO.2006.08.1620. J Clin Oncol. 2007. PMID: 17470858 Clinical Trial.
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.
Fernandez-Martos C, Garcia-Albeniz X, Pericay C, Maurel J, Aparicio J, Montagut C, Safont MJ, Salud A, Vera R, Massuti B, Escudero P, Alonso V, Bosch C, Martin M, Minsky BD. Fernandez-Martos C, et al. Among authors: maurel j. Ann Oncol. 2015 Aug;26(8):1722-8. doi: 10.1093/annonc/mdv223. Epub 2015 May 8. Ann Oncol. 2015. PMID: 25957330 Free article. Clinical Trial.
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
García-Del-Muro X, López-Pousa A, Maurel J, Martín J, Martínez-Trufero J, Casado A, Gómez-España A, Fra J, Cruz J, Poveda A, Meana A, Pericay C, Cubedo R, Rubió J, De Juan A, Laínez N, Carrasco JA, de Andrés R, Buesa JM; Spanish Group for Research on Sarcomas. García-Del-Muro X, et al. Among authors: maurel j. J Clin Oncol. 2011 Jun 20;29(18):2528-33. doi: 10.1200/JCO.2010.33.6107. Epub 2011 May 23. J Clin Oncol. 2011. PMID: 21606430 Clinical Trial.
The controversy of neoadjuvant therapy in rectal cancer.
Maurel J, Pedrosa L, Camps J. Maurel J, et al. Cir Esp (Engl Ed). 2019 Aug-Sep;97(7):361-363. doi: 10.1016/j.ciresp.2019.01.004. Epub 2019 Feb 14. Cir Esp (Engl Ed). 2019. PMID: 30773234 English, Spanish. No abstract available.
209 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page